NCT05098340 Circulating circRNA in Acute Ischemic Stroke
| NCT ID | NCT05098340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-10-01 |
| Primary Completion | 2024-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-10-01 with a primary completion date of 2024-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan * Within 72 hours of symptom onset * Good performance status * Signed an approved informed consents Exclusion Criteria: * a history of hemorrhagic infarction, chronic kidney/liver diseases, peripheral arterial occlusive disease, active malignant disease, and inflammatory or infectious diseases
Frequently Asked Questions
Who can join the NCT05098340 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05098340 currently recruiting?
Yes, NCT05098340 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Affiliated Hospital of Xuzhou Medical University to inquire about joining.
Where is the NCT05098340 trial being conducted?
This trial is being conducted at Xuzhou, China.
Who is sponsoring the NCT05098340 clinical trial?
NCT05098340 is sponsored by The Affiliated Hospital of Xuzhou Medical University. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.